Literature DB >> 12731747

The effect of smoking and caffeine on the fetus and placenta in pregnancy.

O Balat1, A Balat, M G Ugur, S Pençe.   

Abstract

The aim of this study was to determine the effects of tobacco use and consumption of caffeine in pregnancy on the fetus and placenta by measuring the body weights, head circumferences, and lengths of newborns, and also weights and diameters of placentas. In this prospective study, two main groups were chosen for the study: Group I: A total of 63 pregnant non-smokers; were separated into two subgroups according to their daily caffeine intake; less than 300 mg (Ia) (n = 44), and more than 300 mg (Ib) (n = 19). Group II: 60 pregnant smokers were also separated into two subgroups; daily caffeine intake less than 300 mg (IIa) (n = 43), and more than 300 mg (IIb) (n = 17). The newborns and placentas of both groups were examined. The body weights, lengths, and head circumferences of newborns and also weights and diameters of placentas were measured. The pregnant non-smokers consuming caffeine more than 300 mg/day had statistically significant lower weights of newborns and placentas (p < 0.05). However, there was no significant difference between groups according to the lengths, head circumferences of newborns and diameters of placentas. There were significantly lower body weights of newborns and placentas in pregnant smokers (p < 0.05). There was no difference according to the diameters of placentas, and lengths and head circumferences of newborns in either group. In conclusion, it is suggested that smoking in pregnancy should be prevented both for the health of newborns and mothers, and also caffeine including beverages like tea and coffee should be limited in pregnancy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12731747

Source DB:  PubMed          Journal:  Clin Exp Obstet Gynecol        ISSN: 0390-6663            Impact factor:   0.146


  5 in total

Review 1.  Evaluation of the reproductive and developmental risks of caffeine.

Authors:  Robert L Brent; Mildred S Christian; Robert M Diener
Journal:  Birth Defects Res B Dev Reprod Toxicol       Date:  2011-03-02

2.  Caffeine reduces 11β-hydroxysteroid dehydrogenase type 2 expression in human trophoblast cells through the adenosine A(2B) receptor.

Authors:  Saina Sharmin; Haiyan Guan; Andrew Scott Williams; Kaiping Yang
Journal:  PLoS One       Date:  2012-06-11       Impact factor: 3.240

3.  Maternal Caffeine Consumption during Pregnancy and Risk of Low Birth Weight: A Dose-Response Meta-Analysis of Observational Studies.

Authors:  Jongeun Rhee; Rockli Kim; Yongjoo Kim; Melanie Tam; Yizhen Lai; NaNa Keum; Catherine Elizabeth Oldenburg
Journal:  PLoS One       Date:  2015-07-20       Impact factor: 3.240

Review 4.  Use of lipid-lowering medicinal herbs during pregnancy: A systematic review on safety and dosage.

Authors:  Hojjat Rouhi-Boroujeni; Esfandiar Heidarian; Hamid Rouhi-Boroujeni; Minasadat Khoddami; Mojgan Gharipour; Mahmoud Rafieian-Kopaei
Journal:  ARYA Atheroscler       Date:  2017-05

5.  Caffeine use during pregnancy: prevalence of use and newborn consequences in a cohort of French pregnant women.

Authors:  Sandrine Lamy; Estelle Houivet; Jacques Benichou; Stéphane Marret; Florence Thibaut
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2020-02-21       Impact factor: 5.270

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.